Dabigatran Therapy

Dabigatran etexilate mesylate (Pradaxa®) is a medication prescribed to prevent blood clots and strokes in people who have atrial fibrillation, a type of irregular heart rhythm (arrhythmia).
 
People undergoing therapy with dabigatran should be aware of the warnings and precautions associated with this medication before beginning treatment. For example, because this medication is a type of "blood thinner," it can increase the risk for potentially dangerous bleeding problems.
 
Although dabigatran has possible risks, clinical studies have shown that this medication requires less monitoring and is more effective than warfarin (Coumadin®, Jantoven®), another blood thinner used to treat atrial fibrillation.
 
(For more information on this atrial fibrillation therapy, click Dabigatran. This article provides a complete overview of the drug, including information on how it works, general precautions, and potential side effects.)
 
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
eMedTV Links
Copyright © 2006-2014 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.